EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Neurological Manifestations of Hemolytic Uremic Syndrome: A Comprehensive Review

Una Tonkovic, Marko Bogicevic, Aarish Manzar, Nikola Andrejic, Aleksandar Sic iD, Marko Atanaskovic iD, Selena Gajić iD, Ana Bontić, Sara Helena Ksiazek, Ana Mijušković, Nikola M Stojanović iD, Marko Baralić iD

Brain Sciences · 04.07.2025 · 15 (7) · 717

DOI: 10.3390/brainsci15070717 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Brain Sciences, online erschienen am 04.07.2025. Verfasst von Una Tonkovic und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hemolytic uremic syndrome (HUS), a thrombotic microangiopathy primarily affecting the kidneys, can also involve the central nervous system (CNS), often leading to significant morbidity and mortality. Neurologic manifestations are among the most severe extra-renal complications, particularly in children and during outbreaks of Shiga toxin-producing Escherichia coli (STEC)-associated HUS (typical (tHUS)). This review explores the clinical spectrum, pathophysiology, diagnostic workup, and age-specific outcomes of neurologic involvement in both typical (tHUS) and atypical (aHUS). Neurologic complications occur in up to 11% of pediatric and over 40% of adult STEC-HUS cases in outbreak settings. Presentations include seizures, encephalopathy, focal deficits, movement disorders, and posterior reversible encephalopathy syndrome (PRES). Magnetic resonance imaging (MRI) commonly reveals basal ganglia or parieto-occipital lesions, though subtle or delayed findings may occur. Laboratory workup typically confirms microangiopathic hemolytic anemia (MAHA), thrombocytopenia, and kidney damage, with additional markers of inflammation or metabolic dysregulation. Eculizumab is the first-line treatment for aHUS with CNS involvement, while its utility in STEC-HUS remains uncertain. Although many children recover fully, those with early CNS involvement are at greater risk of developing epilepsy, cognitive delays, or fine motor deficits. Adults may experience lingering neurocognitive symptoms despite apparent clinical recovery. Differences in presentation and imaging findings between age groups emphasize the need for tailored diagnostic and therapeutic strategies. Comprehensive neurorehabilitation and long-term follow-up are crucial for identifying residual deficits. Continued research into predictive biomarkers, neuroprotective interventions, and standardized treatment protocols is needed for improving outcomes in HUS patients with neurological complications.

Schlagwörter

Stichwörter der Autor:innen

STEC-HUSatypical HUSbiomarkershemolytic uremic syndromenephrologyneuroimagingpediatric neurologythrombotic microangiopathy

Autor:innen und Institutionen

  • Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
  • Chicago College of Osteopathic Medicine, Midwestern University, Downers Grove, IL 60515, USA.
  • Department of Internal Medicine, Ziauddin Medical College, Karachi 75500, Pakistan.
  • Neurology Clinic, University Clinical Centre of Serbia, Dr Subotica Starijeg Str. 6, 11000 Belgrade, Serbia.
  • Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.
  • Izola General Hospital, 6310 Izola, Slovenia.

ORCID-Profile: Aleksandar Sic, Marko Atanaskovic, Selena Gajić, Nikola M Stojanović, Marko Baralić

Zitieren

APA

Tonkovic, U., Bogicevic, M., Manzar, A., Andrejic, N., Sic, A., Atanaskovic, M., Gajić, S., Bontić, A., Ksiazek, S. H., Mijušković, A., Stojanović, N. M., & Baralić, M. (2025). Neurological Manifestations of Hemolytic Uremic Syndrome: A Comprehensive Review. Brain Sciences, 15(7), 717. https://doi.org/10.3390/brainsci15070717

Vancouver

Tonkovic U, Bogicevic M, Manzar A, Andrejic N, Sic A, Atanaskovic M, et al. Neurological Manifestations of Hemolytic Uremic Syndrome: A Comprehensive Review. Brain Sciences. 2025;15(7):717. doi:10.3390/brainsci15070717

BibTeX
@article{Tonkovic2025,
  author = {Tonkovic, Una and Bogicevic, Marko and Manzar, Aarish and Andrejic, Nikola and Sic, Aleksandar and Atanaskovic, Marko and Gajić, Selena and Bontić, Ana and Ksiazek, Sara Helena and Mijušković, Ana and Stojanović, Nikola M and Baralić, Marko},
  title = {Neurological Manifestations of Hemolytic Uremic Syndrome: A Comprehensive Review},
  journal = {Brain Sciences},
  year = {2025},
  volume = {15},
  number = {7},
  pages = {717},
  doi = {10.3390/brainsci15070717}
}
Kostenlos starten →